Virpax Pharmaceuticals has missed EPS estimates in 2 consecutive quarters.
Over the last 2 quarters, Virpax Pharmaceuticals has averaged an EPS surprise of 26.18% and a revenue surprise of 0.00%.
Analyze the earnings history of Virpax Pharmaceuticals using advanced sorting and filters.
The chart below shows Virpax Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-14 | $-10.75 | $-0.58 | -1753.5 % |
| Q4 | 2024-03-26 | $-96.75 | $-2.70 | -3483.3 % |
The chart below shows Virpax Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.
Virpax Pharmaceuticals (VRPX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 3, 2025 for Q4.
Virpax Pharmaceuticals (VRPX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 3, 2025 for Q4 and the Actual EPS was $-0.37, which missed the estimate of $0.00.
Virpax Pharmaceuticals (VRPX) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on March 3, 2025 for Q4 and the Actual Revenue was $0.00, which hit the estimate of $0.00.